secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001140859-25-000128
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora Q4 adj EPS $3.84 (+15%); revenue $83.7B; raises dividend 9%; new segment structure
--------------------------------------------------------------------------------

- Q4 GAAP diluted EPS $(1.75) (prior yr $0.02); adjusted EPS $3.84 (+15% YoY); revenue $83.7B (+5.9%).
- FY2025 revenue $321.3B (+9.3%); GAAP EPS $7.96; adjusted EPS $16.00 (+16.3%).
- Quarterly dividend increased 9%; long-term guidance raised.
- New reporting structure Q1 FY26: U.S. Healthcare Solutions, Intl Healthcare Solutions, Other (under strategic review: MWI, Profarma, U.S. Consulting).
- U.S. Healthcare Solutions FY2025 op income $3.28B (1.15% margin); Intl Healthcare op income $588M (2.07%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000114085925000128/0001140859-25-000128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000114085925000128/abc-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001140859-25-000128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer